drugset / Trial / NCT00265005
Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if alteplase is effective in dissolving a clot in a catheter in a large vein (central venous line or PICC line) or artery in infants less than 6 months of age.
Timeline
- Start
- 2005-06
- Primary completion
- 2009-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alteplase | Protein / enzyme biologic | 1 mg/ml | Intravenous |
| Subject | Alteplase | Protein / enzyme biologic | 2 mg/ml | Intravenous |